文献速递耳科与耳神经小儿耳鼻咽喉

Osia 2 植入联合同期小耳畸形重建的结局

Outcomes of Osia 2 Implantation With and Without Concurrent Microtia Reconstruction.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-01-31

回顾性病例系列研究纳入2020年6月至2024年12月在某儿童三级中心接受Cochlear Osia 2骨导装置植入的113例患者(129耳),比较同期小耳畸形重建与单纯Osia植入的并发症率,结果显示同期手术安全,并发症率无显著差异。

要点

  • Osia 2植入可安全地与同期小耳畸形重建联合进行。
  • 同期小耳畸形重建与单纯Osia植入的并发症率无显著差异。
  • 既往骨导装置、线圈放置位置及植入物物理特性可能影响结局。

核心结论

  • Osia 2植入可安全地与同期小耳畸形重建联合进行。
  • 既往骨导装置、线圈放置位置及植入物物理特性可能影响术后结局,但需进一步研究。

研究设计与样本

  • 回顾性病例系列研究,纳入2020年6月至2024年12月在某儿童三级中心接受Cochlear Osia 2植入的患者。
  • 共113例病例、129只手术耳;42.5%(n=48)为单纯Osia植入,37.2%(n=42)为同期小耳畸形修复,20.3%(n=23)为其他同期耳科手术。

主要发现

  • 轻微并发症率为10.9%,严重并发症率为14.0%,装置取出率为10.1%。

临床怎么用

  • 对于合并小耳畸形的适合患儿,可考虑Osia 2植入与小耳畸形重建同期进行。
  • 术后并发症评估需关注既往骨导装置使用史、线圈放置位置及植入物物理特性。

局限性

  • 回顾性病例系列设计,可能存在选择偏倚和混杂因素。
  • 样本来自单中心儿童三级中心,结果外推需谨慎。
  • 原文指出需进一步研究以更好描述影响结局的实践和患者因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Cochlear Osia 2 system is a bone-conduction device (BCD) that is effective for conductive, mixed hearing loss, and single-sided deafness. Limited data exist on Osia 2 outcomes in pediatric patients with microtia. This study aimed to compare Osia 2 implantation performed concurrently with microtia reconstruction versus Osia 2 implantation alone, and to investigate surgical techniques and variables impacting complication rates and outcomes. STUDY DESIGN: Retrospective case series. SETTING: Pediatric tertiary care center. METHODS: Patients who underwent Cochlear Osia 2 device implantation between June 2020 and December 2024 were identified. Data was collected on postoperative complications, presence of prior BCD, incision type, coil placement location, and concurrent surgical procedures. Complications were classified as minor or major based upon need for operative intervention. RESULTS: Of the 113 included cases and 129 operated ears, 42.5% (n = 48) underwent Osia implantation alone, 37.2% (n = 42) underwent concurrent microtia repair, and 20.3% (n = 23) underwent other concurrent otologic procedures. Minor complication rate was 10.9%, major complication rate was 14.0%, and device explant rate was 10.1%. Complication rates did not significantly differ between concurrent microtia cases versus Osia alone (19.0% vs 33.8%, RD -14.8%, 95% CI: -35.4% to 9.4%; P = .092), between cases with prior BCD versus those without (42.3% vs 24.1%, RD 18.2%, 95% CI: -8.5% to 44.7%; P = .071), nor between subperiosteal versus subcutaneous coil placement (27.5% vs 27.9%, RD 0.4%, 95% CI: -56.7% to 1.2%; P = .966). CONCLUSION: Osia 2 implantation is safe to perform concurrently with microtia reconstruction. Factors including prior BCD, coil placement location, and implant physical characteristics may impact postoperative outcomes, however, further studies are needed to better characterize practices and patient factors that influence outcomes.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nelson L, Losorelli S, Chang KW, et al. Outcomes of Osia 2 Implantation With and Without Concurrent Microtia Reconstruction. Otolaryngol Head Neck Surg. 2026. PMID: 41618827. doi:10.1002/ohn.70139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。